YUNG Therapist Sidekick | $825,000 | (Oct 4, 2024)
Rezilient Health | $10,000,000 | (Oct 4, 2024)
kapa.ai | $3,200,000 | (Oct 4, 2024)
7BC Venture Capital
United States
- San Francisco, California
- 08/12/2022
- Seed
- Undisclosed Amount
7BC Venture Capital is a venture fund focused on powering the digital economy through AI, FinTech, PropTech, and software technologies. We focus on Late-Stage Seed and Series A rounds from our fund and then fund our existing portfolio companies via SPVs exclusively from our LPs all the way up to exit. 7BC is unique because of its diverse and global set of strategic individual investors backing its funds that support portfolio companies across all stages of growth solving problems, accessing talent, customers, partners, investors, and buyers resulting in successful high-growth transformational companies. Our funds are open to family offices, corporates, and institutional and accredited angel investors. We have developed a unique platform to involve LPs in our process from sourcing to DD, taking board seats, adding value, co-investing and impacting the exit. Our name 7BC rings true as we have Limited Partner investors in our fund from 6 continents including Canada, key tech corridors across the U.S., South America, the UK, Nordics, Europe, the Middle East, Africa, Singapore, Japan and Australia. We have also launched a 506(c) sidecar fund to accommodate smaller LP investors to grow the power of our network and increase our value add to our portfolio companies.
- Industry Venture Capital and Private Equity Principals
- Website https://www.7bc.vc/
- LinkedIn https://www.linkedin.com/company/7bc/
Related People
Andrew RomansInvestor
United States -
Austin, Texas
Based in Austin after 25 years in Silicon Valley, New York & London. My best advice to founders, VCs and members of the startup ecosystem to get ahead: spend 30% of your time doing favors for other people asking for nothing in return. The remaining 70% of your time will be a min 2x more effective giving you a 1.4x boost on your efforts. Raised $48m+ for startups I founded by the age of 28 years old. General Partner, 7BC Venture Capital, General Partner, Rubicon Venture Capital (now fully deployed with 7BC currently investing in growth follow-on rounds of Rubicon portfolio companies). Key differentiators: 1) a sizable network of angel LPs that are VC-backed founders in Silicon Valley, NYC, Austin, Seattle, LA, San Diego and across the US as well as London, Stockholm, Paris, Zurich, Japan, Singapore, Australia, Africa and across LatAm, footprint of active LPs across 6 continents ready to support our startups, 2) corporate network and expertise on CVC give us access to CEOs and c-suites of large corporates and conglomerates which enables us to add value to our startups, 3) track record in top 10% to 12.5% of US VC fund performance.
Experience as a VC, founder and CEO of VC-backed tech ventures, biz dev and sales director, investment banker advising startups and VCs on fundraising and M&A, active angel investor and university professor on Entrepreneurship & VC. Author of two books on VC that are typically both in the top 10 on Amazon and my latest book on blockchain, fintech and digitization of data-driven workflows. Advisor to corporates and governments on VC, CVC and FinTech. I am also a Distinguished Professor of the Practice of Entrepreneurship & Venture Capital at Chapman University. In addition to teaching a class on VC & entrepreneurship at Chapman University one of California’s oldest universities, I have lectured on VC at Stanford, Harvard, UC Berkeley, Santa Clara University, UC San Diego, Georgetown University, London Business School, Imperial College London, University of Bologna, Moscow State University, Tsinghua University Beijing & Shanghai University.
Host of podcast Fireside with a VC
Subscribe on Spotify iTunes and all platforms: anchor.fm/FiresideVC
Video podcast: https://www.youtube.com/c/AndrewRomansVC/videos
Fluent in French & German, conversant in Slovak, lived outside of the US for 15 years and travel to 15+ countries per year (pre-Covid).
Enara Bio | $32,500,000 | (Oct 4, 2024)
Paren | $3,000,000 | (Oct 4, 2024)
Avarra | $8,000,000 | (Oct 4, 2024)
Sober Sidekick by Empathy Health Tech | $2,800,000 | (Oct 4, 2024)
3Laws | $4,100,000 | (Oct 4, 2024)
Reducto | $8,400,000 | (Oct 4, 2024)
Integrated Biosciences, Inc. | $17,000,000 | (Oct 4, 2024)
Mstack Chemicals | $40,000,000 | (Oct 4, 2024)
FLORA (Flora Fertility) | $1,500,000 | (Oct 4, 2024)
AMAKA Studio | $2,000,000 | (Oct 4, 2024)